Chaperones Activate Hepadnavirus Reverse Transcriptase by Transiently Exposing a C-proximal Region in the Terminal Protein Domain That Contributes to Epsilon RNA Binding
Overview
Authors
Affiliations
All hepatitis B viruses replicate by protein-primed reverse transcription, employing a specialized reverse transcriptase, P protein, that carries a unique terminal protein (TP) domain. To initiate reverse transcription, P protein must bind to a stem-loop, epsilon, on the pregenomic RNA template. TP then provides a Y residue for covalent attachment of the first nucleotide of an epsilon-templated DNA oligonucleotide (priming reaction) that serves to initiate full-length minus-strand DNA synthesis. epsilon binding requires the chaperone-dependent conversion of inactive P protein into an activated, metastable form designated P*. However, how P* differs structurally from P protein is not known. Here we used an in vitro reconstitution system for active duck hepatitis B virus P combined with limited proteolysis, site-specific antibodies, and defined P mutants to structurally compare nonactivated versus chaperone-activated versus primed P protein. The data show that Hsp70 action, under conditions identical to those required for functional activation, transiently exposes the C proximal TP region which is, probably directly, involved in epsilon RNA binding. Notably, after priming and epsilon RNA removal, a very similar new conformation appears stable without further chaperone activity; hence, the activation of P protein is triggered by energy-consuming chaperone action but may be completed by template RNA binding.
Villanueva R, Loyola A Biomedicines. 2023; 11(6).
PMID: 37371770 PMC: 10296101. DOI: 10.3390/biomedicines11061674.
Predicted structure of the hepatitis B virus polymerase reveals an ancient conserved protein fold.
Tajwar R, Bradley D, Ponzar N, Tavis J Protein Sci. 2022; 31(10):e4421.
PMID: 36173165 PMC: 9601786. DOI: 10.1002/pro.4421.
Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?.
Pley C, Lourenco J, McNaughton A, Matthews P J Virol. 2022; 96(9):e0005122.
PMID: 35412348 PMC: 9093120. DOI: 10.1128/jvi.00051-22.
Dornbrack K, Beck J, Nassal M PLoS Pathog. 2022; 18(3):e1010362.
PMID: 35259189 PMC: 8903280. DOI: 10.1371/journal.ppat.1010362.
Pathogenicity and virulence of Hepatitis B virus.
Chuang Y, Tsai K, Ou J Virulence. 2022; 13(1):258-296.
PMID: 35100095 PMC: 8812780. DOI: 10.1080/21505594.2022.2028483.